Contact

Payer

Pharma

Provider

Formulary guidance and transparency from P&T to point of care

Trends That Matter for Market Access in Trending Classes

Posted by Matt Breese on Jan 19, 2017

In our weekly Trends that Matter series, we provide engaging infographics from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured topic is market access. Pharma experts regularly analyze market access data for trending classes including diabetes, multiple sclerosis and hemophilia. 

Read More

Topics: Industry Trends, Market Access

Perspectives on Social Media in Pharma

Posted by Matt Breese on Jan 18, 2017

All pharma companies need to be online in some capacity in order to reach their target audiences. Non-personal promotion methods, such as social media marketing, are essential pieces of a successful pharmaceutical sales strategy. 

Read More

Topics: Industry Trends, Branding & Marketing

MMIT Reality Check on Diabetes (Jan 2017)

Posted by Matt Breese on Jan 17, 2017

According to our recent payer coverage analysis for type 2 diabetes treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Read More

Topics: Specialty, Market Access, Branding & Marketing

MMIT Reality Check on Multiple Sclerosis (Jan 2017)

Posted by Matt Breese on Jan 13, 2017

According to our recent payer coverage analysis for multiple sclerosis treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Read More

Topics: Specialty, Market Access, Payer, Branding & Marketing

Trends That Matter for Orphan Drugs

Posted by Matt Breese on Jan 12, 2017

In our weekly Trends that Matter series, we provide engaging infographics from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured pharma topic is orphan drugs. These high-priced drugs treat rare diseases, serving a small group of patients. 

Many healthcare experts predict the sale of orphan drugs will continue to rise. In fact, "Orphan drugs set to be 20.2% of worldwide prescription sales by 2020 (excluding generics,)" reports Andreas Hadjivasiliou, Analyst at EvaluatePharma.

Read More

Topics: Industry Trends

Perspectives on 2017 Drug Pipelines

Posted by Matt Breese on Jan 10, 2017

In 2016, the number of new drugs approved by the FDA significantly decreased from previous years. 2017 will be an important year to watch as products make it from the late-phase pipeline to approval. In order to remain competitive, pharma companies must keep an eye on the market share protection and acquisition activity that impacts the franchise and disease area portfolios of other companies.

Pharma manufacturers must continually monitor the drug pipeline to assess their financial risk. In addition, payers need to be aware of what's coming in order to establish coverage precedents for new drugs and groups of products. Prescribers also need to be aware of new products to understand the clinical and financial benefits to patients.

Read More

Topics: Industry Trends, Product Release

MMIT Reality Check on Hemophilia (Jan 2017)

Posted by Matt Breese on Jan 9, 2017

According to our recent payer coverage analysis for hemophilia treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Read More

Topics: Specialty, Market Access, Payer, Branding & Marketing

Trends That Matter for 2016 Approvals

Posted by Matt Breese on Jan 5, 2017

In our weekly Trends that Matter series, we provide engaging infographics from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured pharma topic is drug approval. In 2016, 22 new drugs were approved by the FDA. 

Read More

Topics: Industry Trends

Perspectives on Biosimilar Development

Posted by Matt Breese on Jan 5, 2017

The Affordable Care Act created a fast-track for biosimilar FDA approvals, which allows manufacturers to get to market much faster than a typical drug. The speed of this process can create more of a surprise attack on existing in-market products in specific disease areas.

Read More

Topics: Specialty, Industry Trends

Perspectives on HCP Facetime Challenges

Posted by Matt Breese on Jan 3, 2017


Health care professionals (HCPs) and medical practices increasingly block pharmaceutical reps from interacting with clinicians. This change has been a major driver for the pharmaceutical industry’s shift towards non-personal promotion programs in recent years.

Many pharma brand marketers are adopting non-personal promotion strategies, strategic partnerships, and digital tools to engage with HCPs. Instead of struggling to break down barriers to secure face-time with HCPs, pharma reps can utilize digital channels to connect within or outside of the clinician’s workflows. Online marketing programs are typically less invasive in the day-to-day lives of clinicians.

Despite this trend, account managers who are in charge of regional or national territories still need to track access for pharmaceutical reps. It is valuable for reps to know which practices block access, restrict access or welcome reps.

Read More

Topics: Industry Trends, Market Access